The average promised employer 401(k) match is 4.6% of pay, and the most common formula on Fidelity’s platform pays 100% on ...

Turning $500,000 into $100,000 of annual income requires a 20% yield, and no durable, diversified income portfolio should be ...

An outdated state funding system forces cities and towns into overrides and service cuts while rewarding decades-old ...

(Alliance News) - Grafton Group PLC on Thursday outlined financial ambitions to 2030, aiming to deliver "attractive earnings growth, strong cash generation and consistent shareholder returns." The ...

Compounded tirzepatide contains the same active ingredient as Mounjaro but may differ in quality, ingredients, and dosage. The Food and Drug Administration (FDA) does not regulate its safety, ...

A $1,000 investment in CVX stock in 2006 now yields 12.1% on cost, as Chevron's annual dividend has grown from $1.80 to $7.12 per share. Chevron has raised its dividend for 39 consecutive years, ...

A recent op-ed in the Washington Post describes the story of an author who decided he wanted to lose weight. Although he was healthy, he heard from friends how easy and effective GLP-1 medications ...

The FDA has clarified its policies regarding GLP-1s, stating that pharmacies must stop compounding GLP-1 drugs once branded versions are removed from the agency’s shortage list, signaling a narrower ...

Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, which Noom said will allow it to expand its behavior change programs and move beyond weight health. Tailor Made provides ...

Drugmaker Eli Lilly says some copycat versions of its GLP-1 medications pose unique safety concerns — here’s what you need to know. A new study funded by Eli Lilly found that mixing compounded ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...